Ensign Peak Advisors »

Trevi Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.5M 465k 11.93

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
Oracle Corporation (ORCL)
Johnson & Johnson (JNJ)

View all positions for Ensign Peak Advisors

Top funds holding Trevi Therapeutics

NEA Management Company
BlackRock
Frazier Life Sciences Management
FMR
Vanguard Group
Vivo Capital
Vanguard Capital Management
Marshall Wace
Rubric Capital Management
Wellington Management Company
MPM Oncology Impact Management
Viking Global Investors
Alliancebernstein
Geode Capital Management
Eventide Asset Management

View all funds holding Trevi Therapeutics